GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Construction In Progress

Ipca Laboratories (BOM:524494) Construction In Progress : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Construction In Progress?

Ipca Laboratories's quarterly construction in progress increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹2,667 Mil) but then declined from Sep. 2023 (₹2,667 Mil) to Dec. 2023 (₹0 Mil).

Ipca Laboratories's annual construction in progress increased from Mar. 2021 (₹1,837 Mil) to Mar. 2022 (₹2,939 Mil) but then declined from Mar. 2022 (₹2,939 Mil) to Mar. 2023 (₹1,222 Mil).


Ipca Laboratories Construction In Progress Historical Data

The historical data trend for Ipca Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Construction In Progress Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 360.90 708.00 1,836.60 2,938.50 1,221.70

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,221.70 - 2,667.40 -

Ipca Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines